Dudediligence.

KALA BIO, Inc

KALANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$8.9MSep ’24−$8.2MDec ’24−$8.9MMar ’25−$11.2MJun ’25−$7.6MSep ’25$686,000Dec ’25−$1.6MMar ’26−$1.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$11.2M$3.9M$0.00$0.00$0.00
Operating income−$130.2M−$81.7M−$39.7M−$41.0M−$39.2M
Net income−$142.6M−$44.8M−$42.2M−$38.5M−$27.0M
Operating cash flow−$108.2M−$78.9M−$27.9M−$29.4M−$32.0M
Cash$92.1M$70.5M$50.9M$51.2M$7.6M
Debt$78.9M$42.9M$34.2M$30.4Mnone on file
Shares outstanding1.3M1.7M2.8M6.1M27.8M